Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis

Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?

(2018) Muhammad Shahzeb Khan et al.  

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)CLINICAL PERSPECTIVE

(2015) Ioana R. Preston et al.   CIRCULATION

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension

(2015) Byung Ju Kang et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis

(2014) Daniel Caldeira et al.   CANADIAN JOURNAL OF CARDIOLOGY

Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study

(2014) Andrew Goudie et al.   EUROPEAN JOURNAL OF HEART FAILURE

Anticoagulation and Survival in Pulmonary Arterial Hypertension

(2013) Karen M. Olsson et al.   CIRCULATION

Formal Synthesis of Antiplatelet Drug, Beraprost

(2011) Naredla Kesava Reddy et al.   ORGANIC LETTERS

Antiplatelet Drugs – Do We Need New Options?

(2010) Sergio Coccheri   DRUGS

The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists

(2010) Ian Adatia et al.   Pediatric Critical Care Medicine